OrthoPediatrics Corp.
NASDAQ:KIDS
25.72 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 148.732 | 122.289 | 98.049 | 71.078 | 72.552 | 57.559 | 45.62 | 37.298 | 31.004 | 23.684 |
| Cost of Revenue
| 54.864 | 31.629 | 24.646 | 16.047 | 17.933 | 14.879 | 11.17 | 10.931 | 9.367 | 7.085 |
| Gross Profit
| 93.868 | 90.66 | 73.403 | 55.031 | 54.619 | 42.68 | 34.45 | 26.367 | 21.637 | 16.599 |
| Gross Profit Ratio
| 0.631 | 0.741 | 0.749 | 0.774 | 0.753 | 0.742 | 0.755 | 0.707 | 0.698 | 0.701 |
| Reseach & Development Expenses
| 10.196 | 8.014 | 5.543 | 5.273 | 5.748 | 4.732 | 3.423 | 2.223 | 1.789 | 1.683 |
| General & Administrative Expenses
| 75.421 | 59.383 | 46.061 | 38.317 | 26.664 | 20.938 | 16.972 | 13.61 | 11.407 | 9.875 |
| Selling & Marketing Expenses
| 51.402 | 45.053 | 39.673 | 31.854 | 31.284 | 26.563 | 20.527 | 16.661 | 15.033 | 12.185 |
| SG&A
| 109.438 | 104.436 | 85.734 | 70.171 | 57.948 | 47.501 | 37.499 | 30.271 | 26.44 | 22.06 |
| Other Expenses
| 2.261 | -1.796 | 1.083 | 0.02 | -0.07 | -0.217 | 0.03 | 1.031 | -0.031 | -0.067 |
| Operating Expenses
| 119.634 | 112.45 | 91.277 | 75.444 | 63.696 | 52.233 | 40.922 | 32.494 | 28.229 | 23.743 |
| Operating Income
| -25.766 | -21.79 | -17.874 | -20.413 | -9.077 | -9.553 | -6.472 | -6.127 | -6.592 | -7.144 |
| Operating Income Ratio
| -0.173 | -0.178 | -0.182 | -0.287 | -0.125 | -0.166 | -0.142 | -0.164 | -0.213 | -0.302 |
| Total Other Income Expenses Net
| 4.454 | 18.101 | 0.486 | -13.254 | -3.608 | -0.217 | 0.03 | 1.031 | -0.031 | -0.067 |
| Income Before Tax
| -21.312 | -3.689 | -17.388 | -33.667 | -12.685 | -12.025 | -8.932 | -6.572 | -7.853 | -9.76 |
| Income Before Tax Ratio
| -0.143 | -0.03 | -0.177 | -0.474 | -0.175 | -0.209 | -0.196 | -0.176 | -0.253 | -0.412 |
| Income Tax Expense
| -0.338 | -4.947 | -1.128 | -0.723 | 4.514 | -0.217 | 2.52 | 2.507 | 1.237 | 2.271 |
| Net Income
| -20.974 | 1.258 | -16.26 | -32.944 | -17.199 | -12.025 | -8.932 | -6.572 | -7.891 | -9.549 |
| Net Income Ratio
| -0.141 | 0.01 | -0.166 | -0.463 | -0.237 | -0.209 | -0.196 | -0.176 | -0.255 | -0.403 |
| EPS
| -0.92 | 0.06 | -0.84 | -1.82 | -1.18 | -0.96 | -1.85 | -0.87 | -1.05 | -1.28 |
| EPS Diluted
| -0.92 | 0.059 | -0.84 | -1.82 | -1.18 | -0.96 | -1.85 | -0.87 | -1.05 | -1.28 |
| EBITDA
| -8.381 | -10.487 | -6.111 | -12.383 | -4.476 | -6.878 | -4.037 | -3.194 | -4.769 | -5.634 |
| EBITDA Ratio
| -0.056 | -0.086 | -0.062 | -0.174 | -0.062 | -0.119 | -0.088 | -0.086 | -0.154 | -0.238 |